Every SEC Form 3/4/5 on record for this filer (CIK 1905248) — 1 issuer, 78 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| LGND | LIGAND PHARMACEUTICALS INC | Chief Financial Officer | 2022-11-07 → 2026-05-28 | 34 | −$6M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| LGND | 2026-03-11 | Sell | 3,057 | $225.00 | $687,825 | 21,010 |
| LGND | 2026-03-04 | Sell | 1,588 | $206.89 | $328,541 | 27,532 |
| LGND | 2026-03-04 | Sell | 1,457 | $205.79 | $299,836 | 29,120 |
| LGND | 2026-03-04 | Sell | 743 | $204.74 | $152,122 | 30,577 |
| LGND | 2026-03-04 | Sell | 668 | $203.63 | $136,025 | 31,320 |
| LGND | 2026-03-04 | Sell | 697 | $202.79 | $141,345 | 31,988 |
| LGND | 2026-03-04 | Sell | 698 | $201.09 | $140,361 | 33,635 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.